Outlook 2022
Annual industry ranking and forecast
Scrip 100
The full Scrip 100 data set for 2022 is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2020).
If you are a subscriber, you may download the data in Excel format.
Novartis Slips Into Pfizer's Number One Pharma Slot Amid Leaderboard Shakeup
Pfizer has dropped to number seven in our top pharma rankings after a long reign. AbbVie has risen to number three, growing through merger expansion.
Infographic: Top 100 Pharma Companies
The Scrip 100 universe gathers FY 2020 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.
Chapter sponsored by:
Understanding The Rationale And Potential Barriers To Diversity And Inclusion In Clinical Trials
The importance of diversity and inclusion in clinical research is nothing new, however the coronavirus pandemic heightened the awareness of the issues that may arise when communities impacted by the disease or virus are underrepresented in clinical trials.
Outlook 2022 e-Book
Download a PDF copy of the Outlook 2022 collection, including Scrip 100 league tables.
Scrip 100 Ranking
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.